Barclays’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,800
Closed -$229K 5433
2024
Q4
$229K Hold
2,800
﹤0.01% 4244
2024
Q3
$231K Sell
2,800
-476,700
-99% -$35.6M ﹤0.01% 4222
2024
Q2
$33.7M Buy
479,500
+266,329
+125% +$19M 0.01% 751
2024
Q1
$15.8M Buy
213,171
+132,171
+163% +$9.21M 0.01% 1116
2023
Q4
$5.36M Buy
+81,000
New +$5.07M ﹤0.01% 2034
2023
Q2
Sell
-677,800
Closed -$39.3M 4874
2023
Q1
$39.3M Buy
677,800
+602,800
+804% +$40.7M 0.02% 572
2022
Q4
$5.43M Buy
+75,000
New +$5.37M ﹤0.01% 1566
2021
Q2
Sell
-200
Closed -$12K 4998
2021
Q1
$12K Sell
200
-551,800
-100% -$30.5M ﹤0.01% 4421
2020
Q4
$25.9M Sell
552,000
-3,000
-0.5% -$130K 0.01% 725
2020
Q3
$20.6M Buy
555,000
+487,900
+727% +$18.5M 0.01% 733
2020
Q2
$2.45M Sell
67,100
-107,300
-62% -$3.74M ﹤0.01% 1925
2020
Q1
$5.33M Sell
174,400
-35,900
-17% -$1.59M ﹤0.01% 1410
2019
Q4
$10.7M Sell
210,300
-121,000
-37% -$5.84M 0.01% 1350
2019
Q3
$15.6M Sell
331,300
-102,400
-24% -$4.88M 0.01% 1028
2019
Q2
$21.5M Buy
433,700
+122,800
+39% +$5.77M 0.01% 883
2019
Q1
$13.2M Sell
310,900
-77,200
-20% -$3.41M 0.01% 1062
2018
Q4
$15.9M Buy
388,100
+54,100
+16% +$2.32M 0.01% 878
2018
Q3
$15.6M Buy
334,000
+50,400
+18% +$2.3M 0.01% 989
2018
Q2
$12.4M Sell
283,600
-152,900
-35% -$7.13M 0.01% 1085
2018
Q1
$20M Sell
436,500
-55,800
-11% -$2.71M 0.02% 843
2017
Q4
$24.9M Sell
492,300
-32,500
-6% -$1.71M 0.02% 694
2017
Q3
$27.3M Sell
524,800
-282,030
-35% -$13.7M 0.03% 532
2017
Q2
$39.5M Buy
806,830
+290,486
+56% +$13.5M 0.04% 352
2017
Q1
$24.3M Sell
516,344
-278,817
-35% -$13.3M 0.03% 479
2016
Q4
$38.2M Buy
795,161
+430,511
+118% +$19.7M 0.04% 342
2016
Q3
$14.4M Buy
364,650
+147,094
+68% +$5.53M 0.02% 678
2016
Q2
$7.72M Sell
217,556
-69,227
-24% -$2.7M 0.01% 996
2016
Q1
$11M Buy
286,783
+7,854
+3% +$294K 0.02% 713
2015
Q4
$11.9M Buy
278,929
+8,976
+3% +$395K 0.01% 803
2015
Q3
$11.3M Buy
269,953
+39,382
+17% +$1.84M 0.01% 862
2015
Q2
$11.3M Buy
230,571
+137,108
+147% +$6.49M 0.01% 959
2015
Q1
$4.17M Sell
93,463
-305,071
-77% -$13.7M ﹤0.01% 1705
2014
Q4
$19.2M Buy
398,534
+105,131
+36% +$4.99M 0.02% 789
2014
Q3
$13.9M Sell
293,403
-159,436
-35% -$7.74M 0.01% 954
2014
Q2
$22.2M Buy
452,839
+7,068
+2% +$331K 0.02% 642
2014
Q1
$20.7M Sell
445,771
-228,551
-34% -$10.5M 0.02% 664
2013
Q4
$31.9M Buy
674,322
+413,008
+158% +$18.5M 0.03% 520
2013
Q3
$10.7M Sell
261,314
-84,599
-24% -$3.65M 0.01% 1091
2013
Q2
$14.1M Buy
+345,913
New +$12.7M 0.02% 843

Other funds holding MET

Barclays's MET Position: Q1 2026 in Review

Barclays increased its MetLife (MET) stake by 22% in Q1 2026, buying an estimated $22M and bringing the position to 1,643,804 shares worth $116M. The position accounts for 0.03% of the portfolio, ranked #447.

Barclays first reported a position in MET in Q2 2013 and has held it in 52 quarters since. The position peaked at $673M in Q4 2021. 1,372 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Barclays held 1,643,804 shares of MetLife worth $116M as of Q1 2026.
  • Barclays bought 293,668 MetLife shares in Q1 2026, an estimated $22M.
  • MetLife made up 0.03% of Barclays's portfolio in Q1 2026, its #447 holding.
  • Barclays first reported a position in MetLife in Q2 2013 and has held it in 52 quarters since.
  • Barclays's MetLife position peaked at $673M in Q4 2021.
  • 1,372 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.